Your browser doesn't support javascript.
loading
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network.
Soekojo, Cinnie Yentia; Kim, Kihyun; Huang, Shang-Yi; Chim, Chor-Sang; Takezako, Naoki; Asaoku, Hideki; Kimura, Hideo; Kosugi, Hiroshi; Sakamoto, Junichi; Gopalakrishnan, Sathish Kumar; Nagarajan, Chandramouli; Wei, Yuan; Moorakonda, Rajesh; Lee, Shu Ling; Lee, Je Jung; Yoon, Sung-Soo; Kim, Jin Seok; Min, Chang Ki; Lee, Jae-Hoon; Durie, Brian; Chng, Wee Joo.
Afiliação
  • Soekojo CY; National University Cancer Institute, Singapore, Singapore.
  • Kim K; Sungkyunkwan University, Samsung Medical Center, Seoul, Korea.
  • Huang SY; National Taiwan University, Taipei City, Taiwan.
  • Chim CS; University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Takezako N; National Hospital Organization Disaster Medical Center, Tachikawa, Japan.
  • Asaoku H; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Kimura H; Northern Fukushima Medical Center, Fukushima, Japan.
  • Kosugi H; Ogaki Municipal Hospital, Ogaki, Japan.
  • Sakamoto J; Tokai Central Hospital, Kakamigahara, Japan.
  • Gopalakrishnan SK; Singapore General Hospital, Singapore, Singapore.
  • Nagarajan C; Singapore General Hospital, Singapore, Singapore.
  • Wei Y; Singapore Clinical Research Institute, Singapore, Singapore.
  • Moorakonda R; Singapore Clinical Research Institute, Singapore, Singapore.
  • Lee SL; Singapore Clinical Research Institute, Singapore, Singapore.
  • Lee JJ; Cheonnam University Hwasoon Hospital, Hwasun-gun, Korea.
  • Yoon SS; Seoul National University Hospital, Seoul, Korea.
  • Kim JS; Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
  • Min CK; Seoul St Mary's Hospital, Seoul, Korea.
  • Lee JH; Gachon University Gil Medical Center, Seongnam-si, Korea.
  • Durie B; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Chng WJ; National University Cancer Institute, Singapore, Singapore. mdccwj@nus.edu.sg.
Blood Cancer J ; 9(10): 83, 2019 10 08.
Article em En | MEDLINE | ID: mdl-31594919
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Blood Cancer J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Singapura País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Blood Cancer J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Singapura País de publicação: Estados Unidos